These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 33669421)

  • 21. Efficacy of various Marek's disease vaccines protocols for prevention of Marek's disease virus-induced immunosuppression.
    Faiz NM; Cortes AL; Guy JS; Fogle JE; Gimeno IM
    Vaccine; 2016 Jul; 34(35):4180-4187. PubMed ID: 27371103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early infection with Marek's disease virus can jeopardize protection conferred by laryngotracheitis vaccines: a method to study MDV-induced immunosuppression.
    Faiz NM; Cortes AL; Guy JS; Fletcher OJ; West M; Montiel E; Gimeno IM
    Avian Pathol; 2016 Dec; 45(6):606-615. PubMed ID: 27207594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A MEQ-deleted Marek's disease virus cloned as a bacterial artificial chromosome is a highly efficacious vaccine.
    Silva RF; Dunn JR; Cheng HH; Niikura M
    Avian Dis; 2010 Jun; 54(2):862-9. PubMed ID: 20608531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant Marek's disease virus (MDV) lacking the Meq oncogene confers protection against challenge with a very virulent plus strain of MDV.
    Lee LF; Lupiani B; Silva RF; Kung HJ; Reddy SM
    Vaccine; 2008 Mar; 26(15):1887-92. PubMed ID: 18313812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Common Live-Attenuated Avian Herpesvirus Vaccine Expresses a Very Potent Oncogene.
    Conradie AM; Bertzbach LD; Bhandari N; Parcells M; Kaufer BB
    mSphere; 2019 Oct; 4(5):. PubMed ID: 31597721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A deletion in the glycoprotein L (gL) gene of U.S. Marek's disease virus (MDV) field strains is insufficient to confer increased pathogenicity to the bacterial artificial chromosome (BAC)-based strain, RB-1B.
    Shaikh SA; Katneni UK; Dong H; Gaddamanugu S; Tavlarides-Hontz P; Jarosinski KW; Osterrieder N; Parcells MS
    Avian Dis; 2013 Jun; 57(2 Suppl):509-18. PubMed ID: 23901769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective efficacy of a recombinant bacterial artificial chromosome clone of a very virulent Marek's disease virus containing a reticuloendotheliosis virus long terminal repeat.
    Mays JK; Black-Pyrkosz A; Spatz S; Fadly AM; Dunn JR
    Avian Pathol; 2016 Dec; 45(6):657-666. PubMed ID: 27258614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential attenuation of Marek's disease virus-induced tumours and late-Marek's disease virus-induced immunosuppression.
    Faiz NM; Cortes AL; Guy JS; Reddy SM; Gimeno IM
    J Gen Virol; 2018 Jul; 99(7):927-936. PubMed ID: 29767614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of Md5-BAC-REV-LTR virus as Marek's disease vaccine in commercial meat-type chickens: protection and immunosuppression.
    Ellington C; Cortes AL; Faiz NM; Mays JK; Fadly A; Silva RF; Gimeno IM
    Avian Pathol; 2021 Dec; 50(6):490-499. PubMed ID: 34463588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of diluting Marek's disease vaccines on the outcomes of Marek's disease virus infection when challenged with highly virulent Marek's disease viruses.
    Gimeno IM; Cortes AL; Montiel ER; Lemiere S; Pandiri AK
    Avian Dis; 2011 Jun; 55(2):263-72. PubMed ID: 21793444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Host genetic resistance to Marek's disease sustains protective efficacy of herpesvirus of turkey in both experimental and commercial lines of chickens.
    Chang S; Xie Q; Dunn JR; Ernst CW; Song J; Zhang H
    Vaccine; 2014 Apr; 32(16):1820-7. PubMed ID: 24530405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation and pathogenic analysis of virulent Marek's disease virus field strain in China.
    Cui N; Su S; Sun P; Zhang Y; Han N; Cui Z
    Poult Sci; 2016 Jul; 95(7):1521-1528. PubMed ID: 26976907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Factors Influencing Efficacy of Vaccine Strain CVI988 Against Marek's Disease in Meat-Type Chickens.
    Gimeno IM; Cortes AL; Faiz NM; Barbosa T; Villalobos T
    Avian Dis; 2015 Sep; 59(3):400-9. PubMed ID: 26478159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morphology of immune organs after very virulent plus strain of Marek's disease virus infection in vaccinated hens.
    Madej JP; Woźniakowski G; Gaweł A
    Pol J Vet Sci; 2016; 19(2):325-35. PubMed ID: 27487506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of immunoprotection between vaccination with meq-deleted Marek's disease virus and vaccine strain CVI988/Rispens].
    Duan L; Su S; Wang Y; Li S; Sun P; Chen W; Cui Z
    Wei Sheng Wu Xue Bao; 2014 Nov; 54(11):1353-61. PubMed ID: 25752142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highly virulent Marek's disease virus strains affect T lymphocyte function and viability of splenocytes in commercial meat-type chickens.
    Gimeno IM; Cortes AL; Reddy SM; López de Juan Abad B; Käser T; Limsatanun A
    Avian Pathol; 2019 Dec; 48(6):564-572. PubMed ID: 31294636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Protective immunity of a meq-deleted Marek's disease virus against very virulent virus challenge in chickens].
    Su S; Li Y; Sun A; Zhao P; Ding J; Zhu H; Cui Z
    Wei Sheng Wu Xue Bao; 2010 Mar; 50(3):380-6. PubMed ID: 20499644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Towards a mechanistic understanding of the synergistic response induced by bivalent Marek's disease vaccines to prevent lymphomas.
    Umthong S; Dunn JR; Cheng HH
    Vaccine; 2019 Oct; 37(43):6397-6404. PubMed ID: 31515142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ability of MEQ-deleted MDV vaccine candidates to adversely affect lymphoid organs and chicken weight gain.
    Dunn JR; Silva RF
    Avian Dis; 2012 Sep; 56(3):494-500. PubMed ID: 23050465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional Profiles Associated with Marek's Disease Virus in Bursa and Spleen Lymphocytes Reveal Contrasting Immune Responses during Early Cytolytic Infection.
    Jin H; Kong Z; Mehboob A; Jiang B; Xu J; Cai Y; Liu W; Hong J; Li Y
    Viruses; 2020 Mar; 12(3):. PubMed ID: 32210095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.